PT1173413E - Utilizacao de derivados do acido 2,4-diamino-3-hidroxicarboxilicos como inibidores de proteassoma - Google Patents

Utilizacao de derivados do acido 2,4-diamino-3-hidroxicarboxilicos como inibidores de proteassoma

Info

Publication number
PT1173413E
PT1173413E PT00927038T PT00927038T PT1173413E PT 1173413 E PT1173413 E PT 1173413E PT 00927038 T PT00927038 T PT 00927038T PT 00927038 T PT00927038 T PT 00927038T PT 1173413 E PT1173413 E PT 1173413E
Authority
PT
Portugal
Prior art keywords
substituted
alkyl
unsubstituted
arylalkyl
formula
Prior art date
Application number
PT00927038T
Other languages
English (en)
Inventor
Patricia Imbach
Carlos Garcia-Echeverria
Dieter Scholz
Pascal Furet
Dennis France
Peter Furst
Johann Zimmermann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1173413E publication Critical patent/PT1173413E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT00927038T 1999-04-27 2000-04-25 Utilizacao de derivados do acido 2,4-diamino-3-hidroxicarboxilicos como inibidores de proteassoma PT1173413E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30077999A 1999-04-27 1999-04-27
US38870099A 1999-09-02 1999-09-02

Publications (1)

Publication Number Publication Date
PT1173413E true PT1173413E (pt) 2004-10-29

Family

ID=26971977

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00927038T PT1173413E (pt) 1999-04-27 2000-04-25 Utilizacao de derivados do acido 2,4-diamino-3-hidroxicarboxilicos como inibidores de proteassoma

Country Status (13)

Country Link
US (1) US20050026994A1 (pt)
EP (1) EP1173413B1 (pt)
JP (1) JP2002543058A (pt)
CN (1) CN100357267C (pt)
AT (1) ATE270268T1 (pt)
AU (1) AU4555800A (pt)
BR (1) BR0010134A (pt)
CA (1) CA2370830C (pt)
DE (1) DE60011889T2 (pt)
ES (1) ES2223512T3 (pt)
HK (1) HK1044931A1 (pt)
PT (1) PT1173413E (pt)
WO (1) WO2000064863A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU49055B (sh) 1996-04-25 2003-08-29 Milenko dipl.ing. Pupović Sto za nameštanje kičme
GB0012795D0 (en) * 2000-05-25 2000-07-19 Novartis Ag Organic compounds
BR0209965A (pt) 2001-05-21 2004-04-06 Alcon Inc Uso de inibidores de nf-kappab para tratar distúrbios do olho seco
US7112588B2 (en) 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
BR0209883A (pt) 2001-05-21 2004-06-08 Alcon Inc Uso de inibidores da proteasoma para o tratamento de distúrbios do olho seco
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
EP1637529A1 (en) * 2004-09-20 2006-03-22 4Sc Ag Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US8459852B2 (en) 2007-10-05 2013-06-11 Dental Equipment, Llc LED-based dental exam lamp
CN102725300B (zh) 2009-12-22 2015-03-11 赛福伦公司 蛋白酶体抑制剂及其制备、纯化、和应用的方法
EP3591048A4 (en) * 2017-01-31 2020-12-23 Chugai Seiyaku Kabushiki Kaisha PROCESS FOR SYNTHESIS OF PEPTIDES IN A CELL-FREE TRANSLATION SYSTEM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5344634A (en) * 1976-10-01 1978-04-21 Kyowa Hakko Kogyo Co Ltd Carcinostatic agent
MX9203836A (es) * 1991-07-02 1993-01-01 Sandoz Ag Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion.
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
DE4331135A1 (de) * 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame valinhaltige Pseudopeptide

Also Published As

Publication number Publication date
BR0010134A (pt) 2002-01-15
DE60011889D1 (en) 2004-08-05
CA2370830C (en) 2009-10-13
CN100357267C (zh) 2007-12-26
DE60011889T2 (de) 2005-07-14
EP1173413A1 (en) 2002-01-23
ATE270268T1 (de) 2004-07-15
WO2000064863A1 (en) 2000-11-02
US20050026994A1 (en) 2005-02-03
JP2002543058A (ja) 2002-12-17
AU4555800A (en) 2000-11-10
EP1173413B1 (en) 2004-06-30
HK1044931A1 (en) 2002-11-08
ES2223512T3 (es) 2005-03-01
CN1351587A (zh) 2002-05-29
CA2370830A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
PT1173413E (pt) Utilizacao de derivados do acido 2,4-diamino-3-hidroxicarboxilicos como inibidores de proteassoma
NO882036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
ATE396988T1 (de) Chinolin- und chianzolinderivate zur behandlung von tumoren
HUP0300798A2 (hu) Szubsztituált triazolopirimidin-származékok és alkalmazásuk rákellenes hatóanyagként és ezeket tartalmazó gyógyszerkészítmények
CY1109558T1 (el) Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων
RU2003116648A (ru) Замещенные имидазопиридины
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
PE20010482A1 (es) Derivados de 3-ureido-pirazol y procedimiento para su preparacion
ES2142861T3 (es) Derivados de 4-(1h-2-metilimidazo(4,5-c)piridinilmetil)fenilsulfonamida como antagonistas del paf.
DE69316067T2 (de) Arzneimittel zur Verwendung bei der Behandlung von Parkinsonismus
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
JP2005538111A5 (pt)
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
BR0207846A (pt) Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
HUP0000189A2 (hu) Biciklusos aril-karboxamid-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk terápiás célokra
MA22895A1 (fr) 7-(2-aminoethyl) benzothiazolones.
DK616388D0 (da) Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
RU2006130865A (ru) Производные пирролопиримидина, применяемые для лечения пролиферативных заболеваний
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
DE60102106D1 (de) Diazacyclooctanverbindungen und ihre therapeutische Verwendung
FR2642758B1 (fr) Derives de pyrimidine,2-(4-((alpha)-heteroaryl-(alpha) aryl-((alpha)-alkyl)-methoxy)-butyl)-1-piperazinyl), avec activite serotoninergique
ATE311182T1 (de) Benzopyranderivate zur behandlung von perihperer gefässerkrankung